ATE477820T1 - Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten - Google Patents
Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patientenInfo
- Publication number
- ATE477820T1 ATE477820T1 AT07425563T AT07425563T ATE477820T1 AT E477820 T1 ATE477820 T1 AT E477820T1 AT 07425563 T AT07425563 T AT 07425563T AT 07425563 T AT07425563 T AT 07425563T AT E477820 T1 ATE477820 T1 AT E477820T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- treatment
- oral administration
- obesity patients
- obesity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07425563A EP2036575B1 (de) | 2007-09-12 | 2007-09-12 | Pharmazeutische Zusammensetzungen zur oralen Verabreichung bei der Behandlung von Adipositas-Patienten |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE477820T1 true ATE477820T1 (de) | 2010-09-15 |
Family
ID=38983405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07425563T ATE477820T1 (de) | 2007-09-12 | 2007-09-12 | Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten |
Country Status (10)
Country | Link |
---|---|
US (1) | US20100221326A1 (de) |
EP (1) | EP2036575B1 (de) |
JP (1) | JP2010539137A (de) |
AT (1) | ATE477820T1 (de) |
AU (1) | AU2008300030A1 (de) |
CA (1) | CA2698882A1 (de) |
DE (1) | DE602007008567D1 (de) |
ES (1) | ES2350798T3 (de) |
PL (1) | PL2036575T3 (de) |
WO (1) | WO2009034171A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100958197B1 (ko) | 2008-02-20 | 2010-05-14 | (주)국전약품 | 올리스타트를 포함하는 약학적 조성물 및 이의 제조 방법 |
BRPI0901602B8 (pt) * | 2009-04-03 | 2021-05-25 | Ems S/A | formulação farmacêuticas |
CN108785272B (zh) * | 2018-09-04 | 2019-04-09 | 中山万汉制药有限公司 | 一种奥利司他软胶囊及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9807655A (pt) * | 1997-02-05 | 2000-02-15 | Hoffmann La Roche | Uso de inibidores de lipase gastrintestinal. |
AR025587A1 (es) * | 1999-09-13 | 2002-12-04 | Hoffmann La Roche | Formulaciones en dispersion que contienen inhibidores de lipasa |
AR025609A1 (es) * | 1999-09-13 | 2002-12-04 | Hoffmann La Roche | Formulaciones lipidas solidas |
WO2003009840A1 (en) * | 2001-07-24 | 2003-02-06 | Lonza Ag | Composition comprising at least one lipase inhibitor and carnitine |
AU2002362061A1 (en) * | 2001-12-04 | 2003-06-17 | Biogal Gyogyszergyar Rt | Preparation of orlistat and orlistat crystalline forms |
DE60330764D1 (de) * | 2002-04-26 | 2010-02-11 | Hoffmann La Roche | Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan |
EP1591114A1 (de) * | 2004-03-12 | 2005-11-02 | Fournier Laboratories Ireland Limited | Verwendung von Metformin und Orlistat zur Behandlung oder Vorbeugung von Obesität |
-
2007
- 2007-09-12 AT AT07425563T patent/ATE477820T1/de not_active IP Right Cessation
- 2007-09-12 PL PL07425563T patent/PL2036575T3/pl unknown
- 2007-09-12 DE DE602007008567T patent/DE602007008567D1/de active Active
- 2007-09-12 EP EP07425563A patent/EP2036575B1/de not_active Not-in-force
- 2007-09-12 ES ES07425563T patent/ES2350798T3/es active Active
-
2008
- 2008-09-12 AU AU2008300030A patent/AU2008300030A1/en not_active Abandoned
- 2008-09-12 US US12/678,066 patent/US20100221326A1/en not_active Abandoned
- 2008-09-12 JP JP2010524504A patent/JP2010539137A/ja active Pending
- 2008-09-12 CA CA2698882A patent/CA2698882A1/en not_active Abandoned
- 2008-09-12 WO PCT/EP2008/062165 patent/WO2009034171A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2008300030A1 (en) | 2009-03-19 |
US20100221326A1 (en) | 2010-09-02 |
DE602007008567D1 (de) | 2010-09-30 |
JP2010539137A (ja) | 2010-12-16 |
EP2036575A1 (de) | 2009-03-18 |
WO2009034171A1 (en) | 2009-03-19 |
EP2036575B1 (de) | 2010-08-18 |
ES2350798T3 (es) | 2011-01-27 |
PL2036575T3 (pl) | 2011-02-28 |
CA2698882A1 (en) | 2009-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
EA201791669A2 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
MX337575B (es) | Compuestos de sulfona y métodos para lafabricación y uso de éstos. | |
EA201290184A1 (ru) | Бензодиазепиновый ингибитор бромодомена | |
LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
DK1970059T3 (da) | Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser | |
EA201100138A1 (ru) | 4-феноксиметилпиперидины в качестве модуляторов активности gpr119 | |
CY1117326T1 (el) | Παραγωγο κατεχολαμινης χρησιμο για τη θεραπεια ασθενειας parkinson | |
DE602006006712D1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren | |
HK1154587A1 (en) | Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators | |
ATE410424T1 (de) | Spirocyclische cyclohexan-derivate | |
EA201071045A1 (ru) | Соединения оксадиазоантрацена для лечения диабета | |
CR9347A (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
CY1115725T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων | |
ATE525070T1 (de) | Silbininkomponente zur behandlung von hepatitis | |
DE502006007982D1 (de) | Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
MY147677A (en) | Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases | |
MA32841B1 (fr) | Composés de cycloundeca depsipeptides et leur utilisation comme médicament | |
CY1116234T1 (el) | Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 | |
ATE541567T1 (de) | Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten | |
CY1114760T1 (el) | Θεραπευτικη αγωγη αθηροσκληρωσης | |
EA201200428A1 (ru) | Композиция и способ для лечения ожирения | |
EA200970849A1 (ru) | Трициклические производные изохинолина для лечения ожирения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |